Target intelligence / Profile preview

Immunoglobulin E (allergen-specific) (IgE)

Target
IgE
Molecular classification
Antibody (Immunoglobulin), Receptor-ligand complex (when cell-bound via FcεRI or CD23)
01

Overview

Immunoglobulin E (IgE) is an antibody found in mammals, synthesized by plasma cells. Its primary physiological role is to mediate immune defense against parasitic infections, but it is most well-known for its involvement in allergic reactions. Allergen-specific IgE circulates at very low concentrations but binds with high affinity to FcεRI (high-affinity IgE receptor) and CD23 (FcεRII, low-affinity receptor) on immune cells—chiefly mast cells, basophils, and some antigen-presenting cells. Upon exposure, cross-linking of cell-bound allergen-specific IgE by allergen triggers cell activation, degranulation, and release of inflammatory mediators such as histamine, leading to symptoms of allergy and, potentially, severe anaphylaxis. Diagnostic tests for allergy rely on detection of specific IgE. Blocking IgE, such as with omalizumab, is used therapeutically in severe allergic and certain autoimmune conditions.

Other names
IgEAllergen-specific IgEIgE antibodyImmune cell-bound IgE
02

Mechanism of action

Blocking IgE binding to FcεRI/CD23 (preventing mast cell/basophil activation) Reducing circulating IgE levels Competing with allergen for IgE binding (immunotherapy)

03

Biological functions

Immune responseMediating Type I hypersensitivity (allergic reaction)Signal transduction (via FcεRI/CD23 on mast cells, basophils, antigen-presenting cells)Defense against parasites
04

Disease associations

Allergic diseases (asthma, rhinitis, urticaria, food allergy, anaphylaxis)Autoimmune diseases (as a pathogenic factor in SLE, rheumatoid arthritis)Infection (parasitic)Other (venom defense)
05

Safety considerations

Risk of immunosuppression (altered parasite defense)Injection-related reactions (with anti-IgE therapy)Anaphylaxis (paradoxical activation if not monitored)
06

Interacting drugs

Omalizumab (Xolair®)

1 more in the full profile.

07

Biomarkers

Allergen-specific IgE (in blood, for allergy diagnosis)Total IgE serum levels

Beyond the preview

Go deeper on Immunoglobulin E (allergen-specific) (IgE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin E (allergen-specific) (IgE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call